Myrtle A. Davis

1.1k total citations
22 papers, 564 citations indexed

About

Myrtle A. Davis is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Myrtle A. Davis has authored 22 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Physiology. Recurrent topics in Myrtle A. Davis's work include Renal and related cancers (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cell death mechanisms and regulation (3 papers). Myrtle A. Davis is often cited by papers focused on Renal and related cancers (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cell death mechanisms and regulation (3 papers). Myrtle A. Davis collaborates with scholars based in United States and Germany. Myrtle A. Davis's co-authors include Seung H. Chang, Benjamin F. Trump, Timothy P. Ryan, Stephen B. Hooser, Shawn P. Clark, George H. Searfoss, M S Reitz, Cornelia Blasig, Philip J. Browning and Andrea Schreier and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Clinical Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Myrtle A. Davis

22 papers receiving 548 citations

Peers

Myrtle A. Davis

ONCOL

EPIDE

PFM

Wanqin Liao China

Feng Shi China

Jun-Ho Jang United States

Fabienne Meier‐Abt Switzerland

Marcin Ratajewski Poland

David J. Seward United States

Kristen A. Mitchell United States

Jacquelyn J. Bower United States

Daniel Knobeloch Germany

Michael R. Bleavins United States

Wanqin Liao China

Myrtle A. Davis

292 ×1.1

105 ×0.7

ONCOL

44 ×0.5

42 ×0.6

EPIDE

41 ×0.6

PFM

Citations per year, relative to Myrtle A. Davis Myrtle A. Davis (= 1×) peers Wanqin Liao

Countries citing papers authored by Myrtle A. Davis

Since Specialization

Citations

This map shows the geographic impact of Myrtle A. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myrtle A. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myrtle A. Davis more than expected).

Fields of papers citing papers by Myrtle A. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myrtle A. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myrtle A. Davis. The network helps show where Myrtle A. Davis may publish in the future.

Co-authorship network of co-authors of Myrtle A. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Myrtle A. Davis. A scholar is included among the top collaborators of Myrtle A. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myrtle A. Davis. Myrtle A. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eldridge, Sandy, Joseph M. Covey, Joel Morris, et al.. (2014). Characterization of acute biliary hyperplasia in Fisher 344 Rats administered the Indole-3-Carbinol Analog, NSC-743380. Toxicology and Applied Pharmacology. 281(3). 303–309. 5 indexed citations

Schweikart, Karen, Sandy Eldridge, Stephanie L. Safgren, et al.. (2014). Comparative Uterotrophic Effects of Endoxifen and Tamoxifen in Ovariectomized Sprague-Dawley Rats. Toxicologic Pathology. 42(8). 1188–1196. 19 indexed citations

Turteltaub, Kenneth W., Myrtle A. Davis, Leigh Ann Burns‐Naas, et al.. (2011). Identification and Elucidation of the Biology of Adverse Events: The Challenges of Safety Assessment and Translational Medicine. Clinical Cancer Research. 17(21). 6641–6645. 9 indexed citations

Engle, Steven K., William H. Jordan, Alan Y. Chiang, et al.. (2009). Qualification of Cardiac Troponin I Concentration in Mouse Serum Using Isoproterenol and Implementation in Pharmacology Studies to Accelerate Drug Development. Toxicologic Pathology. 37(5). 617–628. 35 indexed citations

Clark, Shawn P., Timothy P. Ryan, George H. Searfoss, Myrtle A. Davis, & Stephen B. Hooser. (2008). Chronic Microcystin Exposure Induces Hepatocyte Proliferation with Increased Expression of Mitotic and Cyclin-associated Genes in P53-deficient Mice. Toxicologic Pathology. 36(2). 190–203. 27 indexed citations

Davis, Myrtle A., et al.. (2006). Proteomic Analysis of Rat Liver Phosphoproteins after Treatment with Protein Kinase Inhibitor H89 (N-(2-[p-Bromocinnamylamino-]ethyl)-5-isoquinolinesulfonamide). Journal of Pharmacology and Experimental Therapeutics. 318(2). 589–595. 15 indexed citations

Kolb, Todd M., Ling Duan, & Myrtle A. Davis. (2005). Tsc2 Expression Increases the Susceptibility of Renal Tumor Cells to Apoptosis. Toxicological Sciences. 88(2). 331–339. 10 indexed citations

Davis, Myrtle A.. (2004). Making Mechanistic Connections between Cell Signaling Pathways and Pathological Endpoints. Toxicologic Pathology. 32(1_suppl). 131–135. 1 indexed citations

Davis, Myrtle A.. (2002). Apoptosis methods in pharmacology and toxicology : approaches to measurement and quantification. Humana Press eBooks. 6 indexed citations

10.

Duan, Luchun, et al.. (2002). Phosphoinositol 3 kinase inhibitor, LY294002 increases bcl-2 protein and inhibits okadaic acid-induced apoptosis in Bcl-2 expressing renal epithelial cells. APOPTOSIS. 7(1). 69–76. 16 indexed citations

11.

Davis, Myrtle A.. (2002). Apoptosis Methods in Pharmacology and Toxicology. Humana Press eBooks. 3 indexed citations

12.

Zhang, Lei, Warren J. Gasper, Sanford A. Stass, et al.. (2002). Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2.. PubMed. 62(19). 5463–9. 78 indexed citations

13.

Kolb, Todd M., Seung H. Chang, & Myrtle A. Davis. (2002). Biochemical and Morphological Events During Okadaic Acid-Induced Apoptosis of Tsc2-Null ERC-18 Cell Line. Toxicologic Pathology. 30(2). 235–246. 14 indexed citations

14.

Davis, Myrtle A.. (2000). Effect of Ceramide on Intracellular Glutathione Determines Apoptotic or Necrotic Cell Death of JB6 Tumor Cells. Toxicological Sciences. 53(1). 48–55. 40 indexed citations

15.

Davis, Myrtle A., et al.. (1999). Herbimycin A and Geldanamycin Inhibit Okadaic Acid-Induced Apoptosis and p38 Activation in NRK-52E Renal Epithelial Cells. Toxicology and Applied Pharmacology. 161(1). 59–74. 13 indexed citations

16.

Davis, Myrtle A., et al.. (1998). Review Article: Apoptosis in the Kidney. Toxicologic Pathology. 26(6). 810–825. 30 indexed citations

17.

Davis, Myrtle A., Susan R. Opalenik, Philip J. Browning, et al.. (1997). Expression of Human Herpesvirus 8-Encoded Cyclin D in Kaposi's Sarcoma Spindle Cells. JNCI Journal of the National Cancer Institute. 89(24). 1868–1874. 110 indexed citations

18.

Davis, Myrtle A., Seung H. Chang, & Benjamin F. Trump. (1996). Differential sensitivity of normal and H-ras oncogene-transformed ratkidney epithelial cells to okadaic acid-induced apoptosis. Toxicology and Applied Pharmacology. 141(1). 93–101. 34 indexed citations

19.

Davis, Myrtle A., S-H Chang, & B F Trump. (1995). IP3-mediated cytosolic and nuclear calcium elevation in NRK-52E cells using ‘caged’ GPIP2. Cell Calcium. 17(6). 453–458. 5 indexed citations

20.

Davis, Myrtle A., Mary W. Smith, Seung H. Chang, & Benjamin F. Trump. (1994). Characterization of a Renal Epithelial Cell Model of Apoptosis Using Okadaic Acid and the NRK-52E Cell Line. Toxicologic Pathology. 22(6). 595–605. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact